| P50 | author | Xiaoyuan Chen | Q67123714 |
| | Gang Niu | Q67137291 |
| | Dale O Kiesewetter | Q67137408 |
| | Lixin Lang | Q116997798 |
| P2093 | author name string | Weihua Li | |
| | Lei Zhu | |
| | Ying Ma | |
| | Baozhong Shen | |
| | Xilin Sun | |
| | De-Cai Fang | |
| | Hong-Mei Jia | |
| | Shushu Zhang | |
| P2860 | cites work | Integrins in cancer: biological implications and therapeutic opportunities | Q29614536 |
| | Application of molecular ultrasound for imaging integrin expression | Q30475572 |
| | 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression | Q30497615 |
| | Integrin Targeted MR Imaging | Q33890945 |
| | (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer | Q33956262 |
| | Integrin Targeted Imaging and Therapy | Q34786949 |
| | Why integrin as a primary target for imaging and therapy | Q34912582 |
| | Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT | Q34912643 |
| | Integrin targeting for tumor optical imaging | Q34912662 |
| | Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels | Q35062113 |
| | Multimodality imaging of tumor integrin alphavbeta3 expression | Q36393728 |
| | First experience with clinical-grade ([18F]FPP(RGD₂): an automated multi-step radiosynthesis for clinical PET studies | Q36742890 |
| | Evaluating integrin function in models of angiogenesis and vascular permeability | Q36909861 |
| | Molecular imaging of human epidermal growth factor receptor 2 (HER-2) expression | Q36991929 |
| | Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies | Q37033947 |
| | New insights in vascular development: vasculogenesis and endothelial progenitor cells | Q37317200 |
| | Vascular integrins: therapeutic and imaging targets of tumor angiogenesis | Q37662304 |
| | Multimodality Imaging of Integrin α(v)β(3) Expression | Q37872610 |
| | (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression | Q40023168 |
| | 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis | Q40580104 |
| | PET Imaging of Integrin αVβ3 Expression | Q42726009 |
| | In vitro stability and in vivo clearance of fibrinogen or serum albumin labeled with 77Br, 131I, or 125I by direct or indirect synthetic methods. | Q43500223 |
| | Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. | Q44275821 |
| | Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation | Q44740884 |
| | Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography. | Q48168700 |
| | Continuous surface charge polarizable continuum models of solvation. I. General formalism. | Q51711705 |
| | Optimized indirect (76)Br-bromination of antibodies using N-succinimidyl para-[76Br]bromobenzoate for radioimmuno PET. | Q53937969 |
| | Radiolabeling of a monoclonal antibody with N-succinimidyl para-[77Br]bromobenzoate | Q70231451 |
| | Characterization of bromine-77-labeled proteins prepared using bromoperoxidase | Q71334136 |
| | Synthesis of the 123I- and 125I-labeled cholinergic nerve marker (-)-5-iodobenzovesamicol | Q72750875 |
| | High yield direct 76Br-bromination of monoclonal antibodies using chloramine-T | Q73524505 |
| | Preparation and pharmacological characterization of [76Br]-meta-bromobenzylguanidine ([76Br]MBBG) | Q73537030 |
| | Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting | Q78143346 |
| P921 | main subject | bromine | Q879 |
| P304 | page(s) | 341-353 | |
| P577 | publication date | 2011-08-22 | |
| P1433 | published in | Theranostics | Q21051383 |
| P1476 | title | New Methods for Labeling RGD Peptides with Bromine-76. | |
| P478 | volume | 1 | |